Bekezela Siziba

机构：University of Zimbabwe · ORCID：0009-0007-3495-4207

发表论文 14 篇 · 总被引 822 次 · h-index 7

代表论文

• Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial (2022 · The Lancet · 被引 570)
• Safety, uptake, and use of a dapivirine vaginal ring for HIV-1 prevention in African women (HOPE): an open-label, extension study (2021 · The Lancet HIV · 被引 111)
• Adherence, safety, and choice of the monthly dapivirine vaginal ring or oral emtricitabine plus tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis among African adolescent girls and young women: a randomised, open-label, crossover trial (2023 · The Lancet HIV · 被引 62)
• Baseline preferences for oral pre-exposure prophylaxis (PrEP) or dapivirine intravaginal ring for HIV prevention among adolescent girls and young women in South Africa, Uganda and Zimbabwe (MTN-034/IPM-045 study) (2023 · PLoS ONE · 被引 18)
• Correlates of Adherence to Oral and Vaginal Pre-exposure Prophylaxis (PrEP) Among Adolescent Girls and Young Women (AGYW) Participating in the MTN-034/REACH Trial (2024 · AIDS and Behavior · 被引 11)
• Rejected People: Beggars with Disabilities in the City of Harare, Zimbabwe (2014 · Journals & Books Hosting (International Knowledge Sharing Platform) · 被引 11)